Skip to content

彭南特集团

US · PNTG #3029 按市值排名 上市于 1970
41.87 -0.40 -0.95%
实时 - 追踪5344个代码 - 心跳于17秒前 · 2026-10-16 19:30

估值 各估值倍数与自身5年区间的对比

市净率 3.89 处于历史正常水平 第63百分位
5年平均 3.87 · 在Medical Care Facilities中排名第27/40
市盈率 43.91 处于历史正常水平 第54百分位
5年平均 64.43 · 前瞻 27.71 · 在Medical Care Facilities中排名第26/30
市销率 1.27 高于历史水平 第74百分位
5年平均 1.11 · 前瞻 1.14 · 在Medical Care Facilities中排名第34/50

同业对比 Medical Care Facilities

公司 市值 市盈率(TTM) 市净率 股息率
彭南特集团 (PNTG) 1.46B 46.01 4.07 0.00%
HCA Healthcare (HCA) 99.34B 15.39 -14.96 0.65%
Tenet Healthcare (THC) 21.52B 10.33 4.62 0.00%
Encompass Health (EHC) 12.61B 20.83 4.86 0.59%
DaVita (DVA) 11.95B 15.44 -15.62 0.00%
Fresenius Medical Care (FMS) 11.80B 11.90 0.84 3.85%

StockVane 追踪范围内同行业的其他公司。

Morningstar

★★★☆☆ 合理价值35.11 经济护城河None 不确定性High

当前股价高于晨星合理价值估算16.1%。

合理价值

Pennant Group Inc earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 14% premium over our quantitative fair value estimate of $35.11 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics undermine our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 26.3%, which sits in the bottom 30% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.

The company's unfavorable dividend structure is an additional cause for concern. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, ranks in the bottom 30% globally. This could imply a planned dividend cut or relatively high share price, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

经济护城河

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

作者:Quantitative Equity Report

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

彭南特集团 讨论区 0 条评论

发表评论